Assessments of suicidality in double blind, placebo controlled trials of ziprasidone / Onur N. Karayal en The Journal of Clinical Psychiatry, Año 2011 - Vol.72 - No. 3 (Marzo)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 3 (Marzo) . - pp. 367-375 Título : Assessments of suicidality in double blind, placebo controlled trials of ziprasidone Tipo de documento: texto impreso Autores: Onur N. Karayal, Autor Fecha de publicación: 2022 Artículo en la página: pp. 367-375 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Trastorno bipolar, Piperazinas, Riesgo, Esquizofrenia - farmacoterapia, Ideación suicida, Suicidio, Intento de suicidio. Resumen: A pooled analysis was conducted to identify possibly suicide-related adverse events in Pfizer-sponsored, phases 2-4, placebo-controlled, double-blind, adult and pediatric completed randomized controlled trials of ziprasidone and to evaluate the risk of suicidality with ziprasidone versus placebo. Link: ./index.php?lvl=notice_display&id=27961 [artículo] Assessments of suicidality in double blind, placebo controlled trials of ziprasidone [texto impreso] / Onur N. Karayal, Autor . - 2022 . - pp. 367-375. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 3 (Marzo) . - pp. 367-375 Palabras clave: Antipsicóticos, Trastorno bipolar, Piperazinas, Riesgo, Esquizofrenia - farmacoterapia, Ideación suicida, Suicidio, Intento de suicidio. Resumen: A pooled analysis was conducted to identify possibly suicide-related adverse events in Pfizer-sponsored, phases 2-4, placebo-controlled, double-blind, adult and pediatric completed randomized controlled trials of ziprasidone and to evaluate the risk of suicidality with ziprasidone versus placebo. Link: ./index.php?lvl=notice_display&id=27961

---

1 (1 - 1 / 1)